Health Care & Life Sciences » Pharmaceuticals | MPH Mittelstaendische Pharma Holding AG

MPH Mittelstaendische Pharma Holding AG | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
5,854.20
10,117.00
528.00
983.20
1,238.90
Total Accounts Receivable
18,558.50
21,063.40
88.80
9,465.30
5,519.40
Inventories
31,305.00
35,401.10
-
-
-
Other Current Assets
248.70
1,568.40
67.80
3.30
1,529.90
Total Current Assets
55,966.30
68,149.90
684.70
10,451.70
8,288.10
Net Property, Plant & Equipment
1,706.10
2,405.50
14.00
6.50
4.30
Total Investments and Advances
15,154.90
25,807.10
150,360.10
219,824.10
249,045.60
Intangible Assets
54,354.60
53,561.90
24.30
25.80
17.70
Other Assets
297.90
276.90
21.90
21.90
21.90
Total Assets
127,480.50
150,201.40
151,104.90
230,330.00
257,377.60
ST Debt & Current Portion LT Debt
16,136.70
14,868.70
60.50
-
-
Accounts Payable
7,440.70
7,210.40
638.20
15.30
37.60
Income Tax Payable
-
541.00
-
-
-
Other Current Liabilities
4,046.70
6,024.60
269.60
149.50
192.80
Total Current Liabilities
27,624.10
28,644.70
968.20
164.90
230.40
Long-Term Debt
17,059.30
23,356.10
9,989.30
14,000.00
14,000.00
Provision for Risks & Charges
82.80
27.20
-
-
-
Deferred Taxes
3,519.80
3,443.40
1,127.10
2,216.80
2,481.20
Total Liabilities
48,286.70
55,471.40
12,084.70
16,381.60
16,711.60
Common Equity (Total)
61,571.20
68,770.80
139,020.20
213,948.30
240,665.90
Total Shareholders' Equity
61,571.20
68,770.80
139,020.20
213,948.30
240,665.90
Total Equity
79,193.90
94,730.00
139,020.20
213,948.30
240,665.90
Liabilities & Shareholders' Equity
127,480.50
150,201.40
151,104.90
230,330.00
257,377.60
Accumulated Minority Interest
17,622.70
25,959.20
-
-
-

About MPH Mittelstaendische Pharma Holding

View Profile
Address
GrĂ¼nauer Strasse 5
Berlin Berlin 12557
Germany
Employees -
Website http://mph-ag.de
Updated 07/08/2019
MPH Health Care AG engages in the acquisition and development of companies and shares in companies from the healthcare industry. It focuses on the market of patent-free and patent-protected pharmaceuticals. The company was founded on November 11, 2008 and is headquartered in Berlin, Germany.